Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments

Journal of Biopharmaceutical Statistics

Volumn 16, Issue 2, 2006, Pages 135-150

  Ogungbenro, Kayode ^a   Aarons, Leon ^a   Graham, Gordon ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

GEE; Mixed effects modeling; Nonlinear models; Pharmacokinetics; Power; Sample size

Indexed keywords

ARTICLE; BLOOD SAMPLING; CALCULATION; HUMAN; MONTE CARLO METHOD; PRIORITY JOURNAL; RANDOMIZATION; SAMPLE SIZE; STATISTICAL ANALYSIS;

COMPUTER SIMULATION; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NONLINEAR DYNAMICS; PHARMACOKINETICS; SAMPLE SIZE;

EID: 32844466264     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400500508705     Document Type: Article

References (26)

1. Beal, S. L. (2002). Commentary on significance levels for covariate effects in NONMEM. J. Phamacokinet. Pharmacodyn. 29(4):403-410.
2. Beal, S. L., Sheiner, L. B. (1992). NONMEM Users Guides, Parts I-VII. NONMEM Project Group, San Francisco: University of California.
3. Davidian, M., Giltinan, D. M. (1995). Nonlinear Models for Repeated Measurement, 1st ed. London: Chapman and Hall.
4. Diggle, P. J., Heagerty, P., Liang, K. Y., Zeger, S. L. (2002). Analysis of Longitudinal Data, 2nd ed. New York: Oxford University Press.
5. Duffull, S. B., Retout, S., Mentré, F. (2002). The use of simulated annealing for finding optimal population designs. Comput. Methods Programs Biomed. 69(1):25-35.
6. Jung, S. H., Ahn, C. (2003). Sample size estimation for GEE method for comparing slopes in repeated measurements data. Stat. Med. 22(8):1305-1315.
7. Kang, D., Schwartz, J. B., Verotta, D. (2004). A sample size computation method for nonlinear mixed effects models with applications to pharmacokinetic models. Stat. Med. 23(16):2551-2566.
8. Kowalski, K. G., Hutmacher, M. M. (2001). Design evaluation for a population pharmacokinetic study using clinical trial simulations: a case study. Stat. Med. 20(1):75-91.
9. Lee, P. I. (2001). Design and power of a population pharmacokinetic study. Pharm. Res. 18(1):75-82.
10. Liang, K. Y., Zeger, S. L. (1993). Regression analysis for correlated data. Annu. Rev. Public Health 14:43-68.
11. Liu, A., Shih, W. J., Gehan, E. (2002). Sample size and power determination for clustered repeated measurements. Stat. Med. 21(12):1787-1801.
12. Mentré, F., Mallet, A., Baccar, D. (1997). Optimal design in random-effects regression models. Biometrika 84:429-442.
13. Merle, Y., Mentré, F. (1997). Stochastic optimization algorithms of a Bayesian design criterion for Bayesian parameter estimation of nonlinear regression models: application in pharmacokinetics. Math. Biosci. 144(1):45-70.
14. Retout, S., Mentré, F. (2003a). Further developments of the Fisher information matrix in nonlinear mixed effects models with evaluation in population pharmacokinetics. J. Biopharm. Stat. 13(2):209-227.
15. Retout, S., Mentré, F. (2003b). Optimization of individual and population designs using Splus. J. Pharmacokinet. Pharmacodyn. 30(6):417-443.
16. Retout, S., Duffull, S., Mentré, F. (2001). Development and implementation of the population Fisher information matrix for the evaluation of population pharmacokinetic designs. Comput. Methods Programs Biomed. 65(2):141-151.
17. Retout, S., Mentré, F., Bruno, R. (2002). Fisher information matrix for non-linear mixed-effects models: evaluation and application for optimal design of enoxaparin population pharmacokinetics. Stat. Med. 21(18):2623-2639.
18. Rochon, J. (1995). Sample size calculations for repeated measures experiments. Control. Clin. Trials 16(6):449-452.
19. Rochon, J. (1996). Analyzing bivariate repeated measures for discrete and continuous outcome variables. Biometrics 52(2):740-750.
20. Rochon, J. (1998). Application of GEE procedures for sample size calculations in repeated measures experiments. Stat. Med. 17(14):1643-1658.
21. Tu, X. M., Kowalski, J., Zhang, J., Lynch, K. G., Crits-Christoph, P. (2004). Power analyses for longitudinal trials and other clustered designs. Stat. Med. 23(18):2799-2815.
22. Vonesh, E. F., Wang, H., Majumdar, D. (2001). Generalized least squares, Taylor series linearization and Fisher's scoring in multivariate nonlinear regression. Journal of the American Statistical Association 96(453):282-291.
23. Wahlby, U., Jonsson, E. N., Karlsson, M. O. (2001). Assessment of actual significance levels for covariate effects in NONMEM. J. Pharmacokinet. Pharmacodyn. 28(3):231-252.
24. White, D. B., Walawander, C. A., Liu, D. Y., Grasela, T. H. (1992). Evaluation of hypothesis testing for comparing two populations using NONMEM analysis. J. Pharmacokinet. Biopharm. 20(3):295-313.
25. Zeger, S. L., Liang, K. Y. (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42(1):121-130.
26. Zeger, S. L., Liang, K. Y. (1992). An overview of methods for the analysis of longitudinal data. Stat. Med. 11(14-15):1825-1839.